-transparent.png){kind=logo}
1. The pharmacokinetic profile and protein binding parameters of ceftriaxone were determined in rat, and compared with those of cefotaxime. 2. Plasma concentration-time curves of ceftriaxone and cefotaxime (single i.v. bolus; 100 mg/kg each) were described by a two-compartment, protein-binding model. 3. The corrected VTss (ml/kg) of ceftriaxone was lower than that of cefotaxime. The AUCs of both drugs were similar. The t1/2 beta of the two drugs differed significantly, being 29 min for ceftriaxone and 17 min for cefotaxime. 4. In vivo protein binding constants of both drugs were similar, but the concentrations of protein binding sites differed significantly. The average free fractions in plasma (Fp) of ceftriaxone and cefotaxime were 0.22 and 0.48 respectively. 5. Saturation of the binding site for cefotaxime was estimated to occur at about 30 micrograms/ml in plasma, whereas saturation for ceftriaxone was seen at lower concentrations.
L Hakim, and
D W Bourne, and
E J Triggs
August 1986,
Journal of pharmacokinetics and biopharmaceutics,
L Hakim, and
D W Bourne, and
E J Triggs
April 2009,
Research in veterinary science,
L Hakim, and
D W Bourne, and
E J Triggs
December 1989,
Chest,
L Hakim, and
D W Bourne, and
E J Triggs
September 1981,
Journal of pharmaceutical sciences,
L Hakim, and
D W Bourne, and
E J Triggs
October 1982,
Journal of pharmacokinetics and biopharmaceutics,
L Hakim, and
D W Bourne, and
E J Triggs
January 1991,
Clinical therapeutics,
L Hakim, and
D W Bourne, and
E J Triggs
February 1991,
The Journal of infectious diseases,
L Hakim, and
D W Bourne, and
E J Triggs
January 1984,
Arzneimittel-Forschung,
L Hakim, and
D W Bourne, and
E J Triggs
September 1978,
The Journal of pediatrics,
L Hakim, and
D W Bourne, and
E J Triggs
November 1985,
The Journal of pharmacy and pharmacology,
